Approvals/TGA/COMIRNATY Omicron XBB.1.5 (raxtozinameran) COVID-19 VACCINE 3 micrograms/0.2 mL concentrated suspension for injection multidose vial

Approved

STANDARD

COMIRNATY Omicron XBB.1.5 (raxtozinameran) COVID-19 VACCINE 3 micrograms/0.2 mL concentrated suspension for injection multidose vial

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 717106a6b1bd639e
Product Name: COMIRNATY Omicron XBB.1.5 (raxtozinameran) COVID-19 VACCINE 3 micrograms/0.2 mL concentrated suspension for injection multidose vial
Artg Id: 419332
Artg Name: COMIRNATY Omicron XBB.1.5 (raxtozinameran) COVID-19 VACCINE 3 micrograms/0.2 mL concentrated suspension for injection multidose vial
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2023-12-22
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/6e393674caf909bb76d5374335ba9e63.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/a3a7c889e756272030f6c7533576b6f9.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

717106a6b1bd639e

Type

Standard